VEEV250117P150000
- 0.10
- 0.000.00%
Veeva Systems Newsroom
Q3 Earnings Roundup: Veeva Systems (NYSE:VEEV) And The Rest Of The Vertical Software Segment
Veeva Systems Is Maintained at Overweight by Keybanc
8 Health Care Stocks Whale Activity In Today's Session
KeyBanc Maintains Veeva Systems(VEEV.US) With Buy Rating, Raises Target Price to $255
KeyBanc Cuts Price Target on Veeva Systems to $255 From $285, Keeps Overweight Rating
Veeva Systems (NYSE:VEEV) Will Be Hoping To Turn Its Returns On Capital Around
Veeva Systems (NYSE:VEEV) Shareholders Have Earned a 7.4% CAGR Over the Last Five Years
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Maintains Target Price $195
Evercore's AI Enablers, Adopters and Adapters: CRM, MU, CI, EQT and More
Piper Sandler Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $290
Wells Fargo Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $285
Pulaishi: Multiple factors support the trend of the US stock market in 2025, and the market focus may no longer be on AI.
According to Plaisir, it is expected that the U.S. stock market will gradually rise in the short term, but factors such as an unstable labor market, uncertainty in the new government's policies, and geopolitical tensions will continue to cause fluctuations in the stock market.
Veeva Systems Inc.'s (NYSE:VEEV) Stock Been Rising: Are Strong Financials Guiding The Market?
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Stephens Initiates Veeva Systems(VEEV.US) With Buy Rating, Announces Target Price $280
Express News | Veeva Systems Inc : Stephens Initiates Coverage With Overweight Rating; Target Price $280
ACRO Announces 2025 Officers and New Members
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says
Veeva Systems Is Maintained at Underweight by Morgan Stanley
Morgan Stanley Maintains Veeva Systems(VEEV.US) With Sell Rating, Raises Target Price to $195